Phreesia Research and Development Expenses 2019-2024 | PHR
Phreesia research and development expenses from 2019 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Phreesia Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $112 |
| 2023 | $91 |
| 2022 | $52 |
| 2021 | $23 |
| 2020 | $19 |
| 2019 | $14 |
| 2018 | $11 |
| Phreesia Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-01-31 | $30 |
| 2023-10-31 | $29 |
| 2023-07-31 | $27 |
| 2023-04-30 | $26 |
| 2023-01-31 | $25 |
| 2022-10-31 | $23 |
| 2022-07-31 | $23 |
| 2022-04-30 | $21 |
| 2022-01-31 | $17 |
| 2021-10-31 | $15 |
| 2021-07-31 | $11 |
| 2021-04-30 | $8 |
| 2021-01-31 | $6 |
| 2020-10-31 | $6 |
| 2020-07-31 | $6 |
| 2020-04-30 | $5 |
| 2020-01-31 | $5 |
| 2019-10-31 | $5 |
| 2019-07-31 | $5 |
| 2019-04-30 | $4 |
| 2019-01-31 | |
| 2018-10-31 | $4 |
| 2018-07-31 | $3 |
| 2018-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.205B | $0.356B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.069B | 20.90 |
| Inspire Medical Systems (INSP) | United States | $4.986B | 0.00 |
| Axonics (AXNX) | United States | $3.440B | 0.00 |
| 10x Genomics (TXG) | United States | $3.097B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.080B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.900B | 0.00 |
| Enovis (ENOV) | United States | $2.801B | 20.76 |
| Azenta (AZTA) | United States | $2.782B | 156.36 |
| Hims & Hers Health (HIMS) | United States | $2.640B | 0.00 |
| Privia Health (PRVA) | United States | $2.144B | 119.80 |
| Schrodinger (SDGR) | United States | $1.652B | 0.00 |
| Omnicell (OMCL) | United States | $1.383B | 47.81 |
| Standard BioTools (LAB) | United States | $0.696B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.627B | 0.00 |
| Talkspace (TALK) | United States | $0.477B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.406B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.378B | 0.00 |
| Pulmonx (LUNG) | United States | $0.326B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.306B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.215B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.212B | 0.00 |
| Outset Medical (OM) | United States | $0.159B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| TruBridge (TBRG) | United States | $0.129B | 7.07 |
| MSP Recovery (LIFW) | United States | $0.121B | 0.00 |
| Augmedix (AUGX) | United States | $0.109B | 0.00 |
| 111 (YI) | China | $0.095B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.078B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.020B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |